Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Clinical trial NCT01497899 · COMPLETED

Trial details

NCT number: NCT01497899
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome HIV Infections

Start date: 2011-12-28
Primary completion: 2012-10-17
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.